Candela Invest (CAND) | Financial Analysis & Statements
Candela Invest Inc. | Small-cap | Financial Services
Candela Invest Inc. | Small-cap | Financial Services
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
6.2M
Gross Profit
41.0K
0.66%
Operating Income
-36.2K
-0.58%
Net Income
-1.1M
-17.46%
Balance Sheet Metrics
Total Assets
8.5M
Total Liabilities
6.2M
Shareholders Equity
2.3M
Debt to Equity
2.71
Cash Flow Metrics
Revenue & Profitability Trend
Candela Invest Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 6.2M | 7.0M | 7.8M | 7.2M | 8.2M |
| Cost of Goods Sold | 6.2M | 6.6M | 7.1M | 6.8M | 7.7M |
| Gross Profit | 41.0K | 400.5K | 706.4K | 381.9K | 531.8K |
| Operating Expenses | 27.3K | 37.3K | 26.6K | 42.4K | 0 |
| Operating Income | -36.2K | 317.7K | 586.9K | 253.3K | 531.8K |
| Pre-tax Income | -1.1M | -209.1K | 17.9K | -961.5K | 527.7K |
| Income Tax | -9.6K | -6.7K | 23.1K | 13.1K | 184.9K |
| Net Income | -1.1M | -202.4K | -5.2K | -974.6K | 342.9K |
| EPS (Diluted) | - | -€0.19 | €0.00 | -€0.91 | €0.32 |
Income Statement Trend
Candela Invest Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 6.6M | 6.0M | 9.5M | 6.5M | 9.5M |
| Non-Current Assets | 2.0M | 3.7M | 4.1M | 4.8M | 5.5M |
| Total Assets | 8.5M | 9.7M | 13.6M | 11.2M | 15.0M |
| Liabilities | |||||
| Current Liabilities | 1.2M | 1.3M | 5.0M | 2.6M | 4.8M |
| Non-Current Liabilities | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M |
| Total Liabilities | 6.2M | 6.3M | 10.0M | 7.6M | 9.8M |
| Equity | |||||
| Total Shareholders Equity | 2.3M | 3.4M | 3.6M | 3.6M | 5.2M |
Balance Sheet Composition
Candela Invest Cash Flow Statement
No cash flow data available.
Candela Invest Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
16.22
Price to Book
0.76
Price to Sales
0.29
Profitability Ratios
Profit Margin
-17.47%
Operating Margin
-5.39%
Return on Equity
-38.06%
Return on Assets
-2.01%
Financial Health
Current Ratio
5.32
Debt to Equity
216.99
Beta
0.71
Per Share Data
EPS (TTM)
-€1.01
Book Value per Share
€2.18
Revenue per Share
€5.86
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| cand | 1.8M | 16.22 | 0.76 | -38.06% | -17.47% | 216.99 |
| 1Spatial Plc | 830.1M | 20.20 | 2.67 | 13.92% | 10.82% | 1.68 |
| Anheuser-Busch InBev | 120.4B | 21.06 | 1.57 | 6.60% | 11.75% | 81.53 |
| Viohalco S.A | 1.4B | 8.66 | 0.73 | 6.81% | 2.80% | 93.48 |
| Syneos Health | 6.9B | 377.86 | 1.03 | -1.38% | -1.59% | 28.51 |
| Azelis Group NV | 3.2B | 17.86 | 1.12 | 6.77% | 4.29% | 63.15 |
Financial data is updated regularly. All figures are in the company's reporting currency.